Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 AUD | -3.85% | 0.00% | -26.47% |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX All Ordinaries Index | CI |
Sales 2022 | 5.16M 3.37M | Sales 2023 | 4.21M 2.75M | Capitalization | 127M 83.05M |
---|---|---|---|---|---|
Net income 2022 | -16M -10.44M | Net income 2023 | -15M -9.79M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.23M | Net cash position 2023 | 26.91M 17.56M | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.78% |
1 day | -3.85% | ||
Current month | -7.41% | ||
1 month | -3.85% | ||
3 months | -30.56% | ||
6 months | -26.47% | ||
Current year | -26.47% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | Jan. 07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 23-04-02 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 22-03-31 |
Robert Thomas
CHM | Chairman | 79 | 13-12-03 |
David McIntyre
BRD | Director/Board Member | 53 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.125 | -3.85% | 352,229 |
24-03-27 | 0.13 | 0.00% | 59,110 |
24-03-26 | 0.13 | 0.00% | 407,099 |
24-03-25 | 0.13 | +4.00% | 84,027 |
24-03-22 | 0.125 | 0.00% | 125,174 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.47% | 33.6M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |